Why the Next Billion Dollar Longevity Opportunity May Not Be a Product
Longevity has no shortage of products, science, capital or consumer interest. The bottleneck is translation: getting promising science validated, understood by clinicians, implemented responsibly and ultimately to patients.
We haven't written up this one. Entrepreneur has the full story — the link below goes straight to it.